IT
Iyuda Therapeutics, Inc.
SEC filingBiotechnology · Owings Mills, MD
Amount raised$600Ksold at filing
Total offering$600K
Investors in the raise2count reported to the SEC
FiledApr 6, 2026first sale Mar 23, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Robert TennantExecutive Officer
Ephraim FuchsDirector
Executive officers, directors and promoters as listed on the Form D.